نتایج جستجو برای: ad 40

تعداد نتایج: 415783  

Journal: :iranian biomedical journal 0
ملیحه نوبخت maliheh nobakht سیدمحمد حسینی seyed mohammad hoseini پژمان مرتضوی pejman mortazavi ایرج سهرابی iraj sohrabi بنفشه اسماعیل زاده banafshe esmailzade ناهید رهبر روشندل nahid rahbar rooshandel شیلا امید ظهیر

background: alzheimer’s disease (ad) is a neurodegenerative disorder with progressive loss of cognitive abilities and memory loss. the aim of this study was to compare neuropathological changes in hippocampus and brain cortex in a rat model of ad. methods: adult male albino wistar rats (weighing 250-300 g) were used for behavioral and histopathological studies. the rats were randomly assigned t...

Journal: :Journal of Alzheimer's disease : JAD 2012
Oskar Hansson Erik Stomrud Eugeen Vanmechelen Svante Östling Deborah R Gustafson Henrik Zetterberg Kaj Blennow Ingmar Skoog

Amyloid-β (Aβ) pathology is a major component in the mechanisms behind Alzheimer's disease (AD). Measurement of Aβ(42) in cerebrospinal fluid predicts cognitive decline in patients with mild cognitive impairment and identifies AD in patients with dementia. However, studies on Aβ in plasma are contradictory. In this prospective population-based study, plasma Aβ(42) and Aβ(40) were measured at ba...

2010
Mirko Bibl Hermann Esselmann Piotr Lewczuk Claudia Trenkwalder Markus Otto Johannes Kornhuber Jens Wiltfang Brit Mollenhauer

We studied the diagnostic value of CSF Aβ42/tau versus low Aβ1-42% and high Aβ1-40(ox)% levels for differential diagnosis of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB), respectively. CSF of 45 patients with AD, 15 with DLB, 21 with Parkinson's disease dementia (PDD), and 40 nondemented disease controls (NDC) was analyzed by Aβ-SDS-PAGE/immunoblot and ELISAs (Aβ42 and tau). Aβ4...

Journal: :Experimental neurology 2010
P Lewczuk J Kornhuber E Vanmechelen O Peters I Heuser W Maier F Jessen K Bürger H Hampel L Frölich F Henn P Falkai E Rüther H Jahn Ch Luckhaus R Perneczky K Schmidtke J Schröder H Kessler J Pantel H-J Gertz H Vanderstichele G de Meyer F Shapiro S Wolf M Bibl J Wiltfang

We measured concentrations of Abeta peptides 1-42 and 1-40, and their ratio in plasma of patients carefully categorized clinically and neurochemically as having AD or other dementias with a newly commercially available multiplexing assay, characterized by reasonable laboratory performance (intra-assay imprecision in the range of 1.3-3.8% for Abeta1-42, and 1.8-4.1% for Abeta1-40, inter-assay im...

Journal: :Journal of neuropathology and experimental neurology 2003
Takekazu Kubo Yoshihiro Kumagae Carol A Miller Isao Kaneko

Oligomeric and fibrillar beta-amyloid (Abeta) may be toxic in Alzheimer disease (AD), especially after post-translation modification cumulative over time. Racemization of Ser and Asp residues of Abeta in senile plaques (SPs) occurs as an age-dependent process in AD. We previously reported that Abeta1-40 racemized at Ser26 is soluble and susceptible to proteolysis yielding toxic [D-Ser26]Abeta25...

2017
Paweł Muszyński Magdalena Groblewska Agnieszka Kulczyńska-Przybik Alina Kułakowska Barbara Mroczko

BACKGROUND Growing body of evidence suggests that the pathogenesis of Alzheimer's disease (AD), a progressing neurodegenerative condition, is not limited to the neuronal compartment, but also involves various immunological mechanisms. Insoluble Aβ aggregates in the brain can induce the activation of microglia, resulting in the synthesis of proinflammatory mediators, which further can stimulate ...

2016
Xinhua Zhan Boryana Stamova Lee-Way Jin Charles DeCarli Brett Phinney Frank R. Sharp

OBJECTIVE We determined whether Gram-negative bacterial molecules are associated with Alzheimer disease (AD) neuropathology given that previous studies demonstrate Gram-negative Escherichia coli bacteria can form extracellular amyloid and Gram-negative bacteria have been reported as the predominant bacteria found in normal human brains. METHODS Brain samples from gray and white matter were st...

2012
Rongbiao Pi Xuexuan Mao Xiaojuan Chao Zhiyi Cheng Mengfei Liu Xiaolu Duan Mingzhong Ye Xiaohong Chen Zhengrong Mei Peiqing Liu Wenming Li Yifan Han

We have previously synthesized a series of hybrid compounds by linking ferulic acid to tacrine as multifunctional agents based on the hypotheses that Alzheimer's disease (AD) generates cholinergic deficiency and oxidative stress. Interestingly, we found that they may have potential pharmacological activities for treating AD. Here we report for the first time that tacrine-6-ferulic acid (T6FA), ...

1986
Eva Bagyinszky Young Chul Youn Seong Soo A An SangYun Kim

Alzheimer's disease (AD) is a genetically complex disorder. Mutations in the amyloid precursor protein and presenilin 1 (PS1) genes are fully penetrant and cause early-onset AD. Mutations in presenilin 2, a PS1 homologue, cause partially penetrant autosomal dominant AD with onset age beginning at 40 years and extending past 75 years. A fourth gene, apolipoprotein E (ApoE) is a risk-factor for l...

2018
Ross W. Paterson Catherine F. Slattery Teresa Poole Jennifer M. Nicholas Nadia K. Magdalinou Jamie Toombs Miles D. Chapman Michael P. Lunn Amanda J. Heslegrave Martha S Foiani Philip S. J. Weston Ashvini Keshavan Jonathan D. Rohrer Martin N. Rossor Jason D. Warren Catherine J. Mummery Kaj Blennow Nick C. Fox Henrik Zetterberg Jonathan M. Schott

BACKGROUND Cerebrospinal fluid (CSF) biomarkers are increasingly being used to support a diagnosis of Alzheimer's disease (AD). Their clinical utility for differentiating AD from non-AD neurodegenerative dementias, such as dementia with Lewy bodies (DLB) or frontotemporal dementia (FTD), is less well established. We aimed to determine the diagnostic utility of an extended panel of CSF biomarker...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید